Joel Habener: Difference between revisions
Content deleted Content added
Canada Gairdner International Award 2021 |
Eight96Four (talk | contribs) #suggestededit-add 1.0 Tags: Mobile edit Mobile app edit Android app edit |
||
Line 1: | Line 1: | ||
'''Joel Habener''' is a Professor of Medicine at [[Harvard Medical School]] who has done fundamental studies on elucidating the role of [[incretin]] hormones such as [[Glucagon-like peptide-1|Glucagon-like peptide-1 (GLP-1)]] and [[Glucagon-like peptide-2|Glucagon-like peptide-2 (GLP-2)]]. For his discoveries, he was awarded the 2020 [[Warren Alpert Foundation Prize]] along with [[Daniel J. Drucker|Daniel Drucker]] and Jens Juul Holst.<ref>{{Cite web|url=https://warrenalpert.org/prize-recipients|title=Prize Recipients | Warren Alpert Foundation Prize|website=warrenalpert.org}}</ref> He was elected to the [[National Academy of Sciences]] in 2020.<ref>{{Cite web|url=http://www.nasonline.org/news-and-multimedia/news/2020-nas-election.html|title=2020 NAS Election|website=www.nasonline.org}}</ref> In 2021 he was awarded the [[Canada Gairdner International Award]].<ref>[https://gairdner.org/winners/current-winners/ Canada Gairdner International Award 2021]</ref> |
{{Short description|professor}}'''Joel Habener''' is a Professor of Medicine at [[Harvard Medical School]] who has done fundamental studies on elucidating the role of [[incretin]] hormones such as [[Glucagon-like peptide-1|Glucagon-like peptide-1 (GLP-1)]] and [[Glucagon-like peptide-2|Glucagon-like peptide-2 (GLP-2)]]. For his discoveries, he was awarded the 2020 [[Warren Alpert Foundation Prize]] along with [[Daniel J. Drucker|Daniel Drucker]] and Jens Juul Holst.<ref>{{Cite web|url=https://warrenalpert.org/prize-recipients|title=Prize Recipients | Warren Alpert Foundation Prize|website=warrenalpert.org}}</ref> He was elected to the [[National Academy of Sciences]] in 2020.<ref>{{Cite web|url=http://www.nasonline.org/news-and-multimedia/news/2020-nas-election.html|title=2020 NAS Election|website=www.nasonline.org}}</ref> In 2021 he was awarded the [[Canada Gairdner International Award]].<ref>[https://gairdner.org/winners/current-winners/ Canada Gairdner International Award 2021]</ref> |
||
==References== |
==References== |
Revision as of 04:31, 2 May 2021
Joel Habener is a Professor of Medicine at Harvard Medical School who has done fundamental studies on elucidating the role of incretin hormones such as Glucagon-like peptide-1 (GLP-1) and Glucagon-like peptide-2 (GLP-2). For his discoveries, he was awarded the 2020 Warren Alpert Foundation Prize along with Daniel Drucker and Jens Juul Holst.[1] He was elected to the National Academy of Sciences in 2020.[2] In 2021 he was awarded the Canada Gairdner International Award.[3]
References
- ^ "Prize Recipients | Warren Alpert Foundation Prize". warrenalpert.org.
- ^ "2020 NAS Election". www.nasonline.org.
- ^ Canada Gairdner International Award 2021